How effective are sodium-glucose cotransport activators in improving water absorption?

Abstract

Sodium‐glucose cotransport activators improve water absorption in both experimental models and human subjects. Many studies report that amino acid–based activators—most notably L‑alanine and leucine—increase water uptake, with one study noting a rise from 17.4 to 43.9 μL/min/g (p < 0.001). Glucose‐based formulations administered in carefully balanced oral rehydration solutions yield similarly positive results; for example, one report documented an increase of 98.6 ± 16 μL/min/g (p < 0.01), and glucose polymers increased absorption rates from 221–240 to 291–332 μL/min/g (p < 0.02 to p < 0.005). In addition, interventions such as stevia extract yielded a 1.8‐fold boost in SGLT1‐mediated glucose transport (p < 0.05), an effect linked to improved water uptake. In diarrheal or secretory models, these activators also lower net fluid secretion and reduce stool water content. Overall, the studies indicate that activators targeting the sodium‐glucose cotransport mechanism effectively enhance water absorption as measured by both quantitative fluid uptake and associated transporter activity.

Methods

We analyzed 29 sources from an initial pool of 997, using 7 screening criteria. Each paper was reviewed for 5 key aspects that mattered most to the research question.

Screening

We screened in sources based on their abstracts that met these criteria:

• SGLT Activators/Enhancers: Does this study investigate sodium-glucose cotransporter (SGLT) activators or enhancers?
• Water Absorption Outcome: Does this study measure water absorption as a primary or secondary outcome?
• In Vivo Studies: Is this an in vivo study (human studies or animal studies conducted in living systems)?
• Appropriate Study Design: Is this study one of the following designs: randomized controlled trial, controlled clinical trial, cohort study, case-control study, systematic review, or meta-analysis?
• SGLT Activators vs Inhibitors: Does this study focus on SGLT activators/enhancers rather than focusing solely on SGLT inhibitors?
• Beyond In Vitro Only: Does this study include in vivo components rather than being limited to in vitro studies only?
• Publication Quality: Is this study a peer-reviewed research article?

Results

Characteristics of Included Studies

• Study Design:

  • 23 studies were animal experimental.
  • 6 studies were human intervention studies.

• Clinical Condition and Species:

  • 12 studies used diarrhea models.
  • 7 studies used normal (healthy) animals or humans.

• Intervention Type:

  • 6 studies tested amino acids or protein hydrolysate.
  • 6 studies tested oral rehydration solution composition.

Water Absorption Outcomes

Summary of water absorption effects:

• Activator types:

  • 6 studies used amino acids.
  • 6 studies used glucose.

• Reported effects:

  • Increased or enhanced water absorption was reported in 14 studies.

Sodium Absorption Outcomes

Summary of sodium absorption effects:

• Activator types:

  • Amino acid-based activators were used in 6 studies.
  • Glucose or glucose analogs were used in 9 studies.

• Reported effects:

  • Increased sodium absorption or transporter activity was reported in 19 studies.

Comparative Effectiveness of Different Activators

Summary of comparative effectiveness:

• Amino acid activators compared in 5 studies, with alanine/protein hydrolysate often being most effective.

Context-Dependent Effects and Generalizability

• The magnitude of effect was often greater in diarrheal or secretory models than in healthy controls.

References

• Study Conducted by Wapnir et al. (1988)
• Study Conducted by Rongione et al. (2001)